Moderna and Pfizer have both begun large-scale clinical trials with 30,000 participants on their respective vaccines, with the hopes of obtaining regulatory approval and widespread distribution by the end of 2020. The Moderna and Pfizer…
With the need for simple, point-of-care testing that provides rapid results continuing to grow across the United States, scientists from the National Institutes of Health (NIH) recently introduced the Rapid Acceleration of Diagnostics…
Periodontal diseases are related to an immunoinflammatory response to various types of oral biofilm. They affect approximately 42% of United States adults. Chronic periodontitis is characterized by alveolar bone loss, attachment loss, and…
As SARS-CoV-2 is known to spread via aerosols during medical procedures and possibly in other instances, it is hoped that germicidal ultraviolet (UV) light may inactivate virus-carrying microbes, helping to disinfect the air in indoor…
The application deadline to apply for financial support through the United States Department of Health and Human Services (HHS) Provider Relief Fund Payment Portal has been extended from July 24 to August 3, 2020. The more than $4 billion…
Young Innovations is excited to introduce Splatter Guard, an innovative new prophy angle that reduces splatter by up to 15 times* compared to traditional prophy angles.